The clinical characteristics and prognostic factors of multiple lesions in glioblastomas

[1]  S. Sangkhathat,et al.  Temozolomide for patients with wild-type isocitrate dehydrogenase (IDH) 1 glioblastoma using propensity score matching , 2020, Clinical Neurology and Neurosurgery.

[2]  Dong Kyu Lee,et al.  Survival analysis: part II – applied clinical data analysis , 2019, Korean journal of anesthesiology.

[3]  J. Debus,et al.  Survival and recurrence patterns of multifocal glioblastoma after radiation therapy , 2018, Cancer management and research.

[4]  Sanguansin Ratanalert,et al.  Butterfly Tumor of the Corpus Callosum: Clinical Characteristics, Diagnosis, and Survival Analysis , 2017, Journal of Neurosciences in Rural Practice.

[5]  F. Gaillard,et al.  Multifocal and multicentric glioblastoma: Improved characterisation with FLAIR imaging and prognostic implications , 2016, Journal of Clinical Neuroscience.

[6]  F. Gaillard,et al.  The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma , 2016, Journal of Neuro-Oncology.

[7]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[8]  Jayesh Sardhara,et al.  Multiple glioblastomas: Are they different from their solitary counterparts? , 2015, Asian journal of neurosurgery.

[9]  Yuexin Liu,et al.  Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma , 2015, Acta Neuropathologica.

[10]  J. Hay,et al.  The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United States. , 2013, Neuro-oncology.

[11]  R. Lober,et al.  The incidence and significance of multiple lesions in glioblastoma , 2013, Journal of Neuro-Oncology.

[12]  Mitchel S Berger,et al.  Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. , 2012, Journal of neurosurgery.

[13]  K. Black,et al.  Prognosis of patients with multifocal glioblastoma: a case-control study. , 2012, Journal of neurosurgery.

[14]  S. Inoue,et al.  D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function. , 2012, Genes & development.

[15]  Bin Wu,et al.  Subgroup Economic Analysis for Glioblastoma in a Health Resource-Limited Setting , 2012, PloS one.

[16]  Nicholas B. Levine,et al.  Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article. , 2011, Journal of neurosurgery.

[17]  R. Stupp,et al.  Cost–effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme , 2009, Expert review of pharmacoeconomics & outcomes research.

[18]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[19]  Sooriyarachchi,et al.  Use of Schoenfeld’s global test to test the proportional hazards assumption in the Cox proportional hazards model: an application to a clinical study , 2009 .

[20]  Maiwenn J Al,et al.  Cost‐effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme , 2008, Cancer.

[21]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[22]  R. Mirimanoff,et al.  Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost‐identification analysis of concomitant and adjuvant treatment with temozolomide until patient death , 2004, Cancer.

[23]  C. Mann,et al.  Observational research methods. Research design II: cohort, cross sectional, and case-control studies , 2003, Emergency medicine journal : EMJ.

[24]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[25]  H. Abe,et al.  Clinicopathological study of multiple gliomas--report of three cases. , 1990, Neurologia medico-chirurgica.

[26]  D. Karnofsky,et al.  The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .